HuMax-Her2™ is a fully human antibody targeted to the Human Epidermal growth factor Receptor 2 (Her2), a protein whose normal function is signaling involved in growth, differentiation, motility and adhesion. Her2 is over-expressed on many solid tumors including breast cancer. Lead candidates show differentiated binding characteristics from Her2 antibody therapies currently available.